Literature DB >> 12807883

Mutagenesis of the Runt domain defines two energetic hot spots for heterodimerization with the core binding factor beta subunit.

Lina Zhang1, Zhe Li, Jiangli Yan, Padmanava Pradhan, Takeshi Corpora, Matthew D Cheney, Jerónimo Bravo, Alan J Warren, John H Bushweller, Nancy A Speck.   

Abstract

Core-binding factors (CBFs) are a small family of heterodimeric transcription factors that play critical roles in several developmental pathways and in human disease. Mutations in CBF genes are found in leukemias, bone disorders, and gastric cancers. CBFs consist of a DNA-binding CBF alpha subunit (Runx1, Runx2, or Runx3) and a non-DNA-binding CBF beta subunit. CBF alpha binds DNA in a sequence-specific manner, whereas CBF beta enhances DNA binding by CBF alpha. Both DNA binding and heterodimerization with CBF beta are mediated by a single domain in the CBF alpha subunits known as the "Runt domain." We analyzed the energetic contribution of amino acids in the Runx1 Runt domain to heterodimerization with CBF beta. We identified two energetic "hot spots" that were also found in a similar analysis of CBF beta (Tang, Y.-Y., Shi, J., Zhang, L., Davis, A., Bravo, J., Warren, A. J., Speck, N. A., and Bushweller, J. H. (2000) J. Biol. Chem. 275, 39579-39588). The importance of the hot spot residues for Runx1 function was demonstrated in in vivo transient transfection assays. These data refine the structural analyses and further our understanding of the Runx1-CBF beta interface.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12807883     DOI: 10.1074/jbc.M303972200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

1.  ETO, but not leukemogenic fusion protein AML1/ETO, augments RBP-Jkappa/SHARP-mediated repression of notch target genes.

Authors:  Daniela Salat; Robert Liefke; Jörg Wiedenmann; Tilman Borggrefe; Franz Oswald
Journal:  Mol Cell Biol       Date:  2008-03-10       Impact factor: 4.272

2.  Accurate germline RUNX1 variant interpretation and its clinical significance.

Authors:  Simone Feurstein; Liying Zhang; Courtney D DiNardo
Journal:  Blood Adv       Date:  2020-12-22

3.  Downregulation of RUNX1/CBFβ by MLL fusion proteins enhances hematopoietic stem cell self-renewal.

Authors:  Xinghui Zhao; Aili Chen; Xiaomei Yan; Yue Zhang; Fuhong He; Yoshihiro Hayashi; Yunzhu Dong; Yalan Rao; Bo Li; Rajeana M Conway; Alba Maiques-Diaz; Shannon E Elf; Nuomin Huang; Johannes Zuber; Zhijian Xiao; William Tse; Daniel G Tenen; Qianfei Wang; Wei Chen; James C Mulloy; Stephen D Nimer; Gang Huang
Journal:  Blood       Date:  2014-01-21       Impact factor: 22.113

4.  Disease mutations in RUNX1 and RUNX2 create nonfunctional, dominant-negative, or hypomorphic alleles.

Authors:  Christina J Matheny; Maren E Speck; Patrick R Cushing; Yunpeng Zhou; Takeshi Corpora; Michael Regan; Miki Newman; Liya Roudaia; Caroline L Speck; Ting-Lei Gu; Stephen M Griffey; John H Bushweller; Nancy A Speck
Journal:  EMBO J       Date:  2007-02-08       Impact factor: 11.598

5.  PRMT1 interacts with AML1-ETO to promote its transcriptional activation and progenitor cell proliferative potential.

Authors:  Wei-Jong Shia; Akiko J Okumura; Ming Yan; Ali Sarkeshik; Miao-Chia Lo; Shinobu Matsuura; Yukiko Komeno; Xinyang Zhao; Stephen D Nimer; John R Yates; Dong-Er Zhang
Journal:  Blood       Date:  2012-04-12       Impact factor: 22.113

6.  CBFbeta is critical for AML1-ETO and TEL-AML1 activity.

Authors:  Liya Roudaia; Matthew D Cheney; Ekaterina Manuylova; Wei Chen; Michelle Morrow; Sangho Park; Chung-Tsai Lee; Prabhjot Kaur; Owen Williams; John H Bushweller; Nancy A Speck
Journal:  Blood       Date:  2009-01-29       Impact factor: 22.113

Review 7.  Transcription factor mutations as a cause of familial myeloid neoplasms.

Authors:  Jane E Churpek; Emery H Bresnick
Journal:  J Clin Invest       Date:  2019-02-01       Impact factor: 14.808

8.  Distinct contributions of conserved modules to Runt transcription factor activity.

Authors:  Pegine B Walrad; Saiyu Hang; Genevieve S Joseph; Julia Salas; J Peter Gergen
Journal:  Mol Biol Cell       Date:  2010-05-12       Impact factor: 4.138

9.  Cooperative binding of DNA and CBFbeta to the Runt domain of the CBFalpha studied via MD simulations.

Authors:  Bahru Habtemariam; Victor M Anisimov; Alexander D MacKerell
Journal:  Nucleic Acids Res       Date:  2005-07-26       Impact factor: 16.971

10.  A novel RUNX2 missense mutation predicted to disrupt DNA binding causes cleidocranial dysplasia in a large Chinese family with hyperplastic nails.

Authors:  Shaohua Tang; Qiyu Xu; Xueqin Xu; Jicheng Du; Xuemei Yang; Yusheng Jiang; Xiaoqin Wang; Nancy Speck; Taosheng Huang
Journal:  BMC Med Genet       Date:  2007-12-31       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.